The Assistance Fund Opens New Program for Neurofibromatosis
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With NeurofibromatosisORLANDO, FL / ACCESSWIRE / January 8,...
Year: 2024
Dexios Chooses Maverick Medical AI as Its AI Medical Coding Solution
Through this partnership, Dexios will leverage Maverick’s AI-powered Autonomous Medical Coding Platform to help scale its operations, improve consistency across...
Tivic Health Announces Launch of New and Improved ClearUP 2.0
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine,...
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
The Company’s global patent portfolio includes granted patents in the United States, Europe, India, Australia, China and Hong Kong, and...
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
LivaNova to Wind Down Advanced Circulatory Support Business Unit
Move Reinforces Focus on Core Cardiopulmonary and Neuromodulation Businesses ACS Standalone Cannulae Products and Accessories to Transition Into Cardiopulmonary Business...
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
LAVAL, QC / ACCESSWIRE / January 8, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals,...
GE HealthCare announces agreement to acquire MIM Software
The anticipated acquisition aligns to GE HealthCare’s precision care strategy with the goal of strengthening the company’s digital solutions across...
bioAffinity Technologies In the News
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company...
Accenture Invests in QuantHealth to Accelerate Use of AI-powered Clinical Trial Simulations to Drive Cost-Effective Drug Development
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced it has made a strategic investment, through Accenture Ventures, in...
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has entered into a definitive agreement to be acquired by...
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:...
Izotropic Provides Regulatory and Operational Updates
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
MentalHealth.com Acquires Online Mental Health Platform and Community
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2024 / Leading patient-first health technology company MentalHealth.com is pleased to announce...
Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)
KELOWNA BC / ACCESSWIRE / January 8, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF), a pioneering clinical-stage...
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference
Company announces product sales for 2023 of approximately $6.7 billion (unaudited); U.S. COVID-19 market share season to date increased to...
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
PharmAla to present its intellectual property assets to potential partners at the annual JPM healthcare conference on January 8-11th in...
GeneDx Announces Preliminary 2023 Financial Results
Expects to exceed revised 2023 revenue guidance with fourth quarter 2023 revenue from continuing operations1 of more than $57M with...
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit Altamira’s...